Medidata Study Experience

  1. New Research On Concurrence Of CRS & ICANS In CAR T-cell Treatments 5/23/2023

    Gain insight into the latest advancements in AI-driven investigations, shedding light on the complexities of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapies.

  2. Enhancing Clinical Trials By Linking Them To RWD 5/16/2023

    Learn how integrating participant trial data and real-world data into a standard EDC system can promote success in obtaining IRB approval.

  3. Linking Clinical Trial Data With Real-World Data: Q&A With HealthVerity 5/16/2023

    Director of Partners and Alliance Management at HealthVerity KC Ahlberg discusses some key trends related to the use of real-world data in clinical trials, and the value sponsors are realizing through data linkage.

  4. How To Double High-Performing Site Count In A Priority Indication 3/13/2023

    A top 10 biopharmaceutical company wanted to expand its site list in a priority indication and better understand how existing sites in their database performed. Find out what happened next.

  5. The State Of Black Participation In Clinical Trials 2/24/2023

    The need to design trials enrolling more demographically diverse patients is widely recognized. Learn why implementing effective, sustainable, and scalable enrollment diversity strategies remains a challenge for biopharmaceutical companies.

  6. Intelligent Trials - Diversity 2/17/2023

    Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.

  7. New Therapeutic And Diagnostic Avenues In Breast Cancer 1/24/2023

    This podcast discusses an important metastatic breast cancer study that was recently published in the New England Journal of Medicine and presented at ASCO - the American Society of Clinical Oncology in June 2022.

  8. A New Avenue In Breast Cancer Therapeutics 1/23/2023

    Clinical trial findings may have unlocked a groundbreaking opportunity for breast cancer patients: beneficial therapy for HER2-negative patients with HER2-directed antibody-drug conjugates.

  9. 3 Data Linkage Use Cases To Future Proof Your Clinical Trials 12/20/2022

    Discover why access to compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes. 

  10. The Future Of Data Linkage In Clinical Trial Evidence Generation 12/20/2022

    Explore key questions about the future of AI and data linkage in clinical trial evidence generation.